Argenta Announces Record Year for Peer-Reviewed Publications
News Dec 10, 2013
Argenta has announced that 2013 has seen a record number of peer-reviewed publications featuring its scientists as co-authors with its clients and collaborators. The 2013 total of 15 publications surpasses the previous record of 13 achieved in 2007.
The publications have been co-authored with clients such as Genentech, AstraZeneca and Corcept and include papers in such prestigious journals as Nature and Proceedings of the National Academy of the USA.
Details of these, and other Argenta publications, can be found on the company’s website: http://www.argentadiscovery.com/news/publications.htm.
Dr John Montana, Managing Director of Argenta, commented, “Argenta stands or falls by the quality of the science that it conducts for and together with its clients. This record number of publications in high-quality, peer-reviewed scientific journals is another indication of the scientific prowess of Argenta’s industry-experienced staff and the success that we have achieved in partnership with our clients”.
A further indication of Argenta’s strength in drug discovery is the 40 development compounds that it has delivered on behalf of its clients during the 13 years since its inception.
The clinical progress of some of these can be seen on the company’s website: http://www.argentadiscovery.com/about/candidate-compound-progression.htm.
Electron Microscope Detector Achieves Record ResolutionNews
Like driving at night and being able to read the license plate of an oncoming car without being blinded by the lights.READ MORE
Chemistry Professor Awarded Prestigious Steenbock ProfessorshipNews
University of Wisconsin–Madison Professor of Chemistry Shannon Stahl has received the Steenbock Professorship in Chemical Sciences. In addition to advancing the fundamental science in this area, Stahl has been involved in numerous industrial collaborations that have led to practical applications, including target applications relevant to pharmaceutical synthesis.READ MORE
Enabling Technology in Cell-Based Therapies: Scale-Up, Scale-Out or Program In-PlaceNews
Technologies are reducing costs and changing the ways in which researchers and clinicians process and use therapeutic cells. Two new review articles detail the status of cell bioreactors in both stem cell and tissue/organ engineering applications.READ MORE
15th International Conference and Exhibition on Metabolomics & Systems
Apr 29 - Apr 30, 2019